NCT00919399
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- CHU de Toulouse Rangueil Toulouse, France
- Institut Claudius Regaud Toulouse, France
Clinical trial condition
Breast Neoplasms
Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.
699 public trials
115 recruiting studies
Breast Neoplasms trial results
Completed
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
NCT00385177
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +22 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Completed
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
NCT00063570
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Aurora, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Plantation, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Morrisville, North Carolina, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Philadelphia, Pennsylvania, United States
NCT00036023
- Conditions
- Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +33 more
- Locations
-
Not specified
NCT00300508
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Research Site Amstetten, Austria
- Research Site Bad Ischl, Austria
- Research Site Baden, Austria
- Research Site Bregenz, Austria
NCT00120939
- Conditions
- Adnexal Diseases, Astrocytoma, Breast Diseases, +69 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
NCT00268125
- Conditions
- Breast Diseases, Breast Neoplasms, Nausea, +8 more
- Locations
-
- Centre Oscar Lambret Lille, France
- Centre Paul STRAUSS Strasbourg, France
- Institut Claudius Regaud Toulouse, France
NCT00043368
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- Pfizer Investigational Site Berkely, California, United States
- Pfizer Investigational Site Gilroy, California, United States
- Pfizer Investigational Site Hollister, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
Completed
Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer
NCT00174434
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Pfizer Investigational Site Harvey, Illinois, United States
- Pfizer Investigational Site Harvey, Illinois, United States
- Pfizer Investigational Site Indianapolis, Indiana, United States
- Pfizer Investigational Site Indianapolis, Indiana, United States
NCT00612443
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States